U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07948070) titled 'A Phase I/II Open-label Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of Rejuvenated Tumor-Reactive T Cells (GKPTZ-01) in Subjects With Pancreatic Cancer' on Nov. 13.
Brief Summary: A Phase I/II Open-label Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of Rejuvenated Tumor-Reactive T Cells (GKPTZ-01) in Subjects with Pancreatic Cancer
Study Start Date: June 02
Study Type: INTERVENTIONAL
Condition:
Pancreatic Cancer
Intervention:
DRUG: GKPTZ-01 in Combination with Adjuvant Chemotherapy
Combination with Adjuvant Chemotherapy
DRUG: GKPTZ-01
GKPTZ-01
DRUG: GKPTZ-01 in Combin...